Kv1.3
Publication - Journal of Biological Chemistry

We are thrilled to announce that our second publication has been accepted by the Journal of Biological Chemistry!

This work details the expression of Kv1.3 and its close homologs, which has been crucial in achieving best-in-class, extremely selective inhibitors. Our project aims to cure patients with autoimmune diseases through an immune-sparing mechanism of action.

https://www.jbc.org/article/S0021-9258(24)01650-8/fulltext

Introduction
Link icon purple
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
March 12, 2024
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
March 12, 2024
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
Introduction
Link icon purple
Latest
News
The latest industry news, interviews, technologies, and resources.
View All News
Team
May 14, 2024
By VRG Therapeutics
First stage gating meeting of the year
White arrow icon up and right direction redirecting to Partner with US page
Combi-X
VRG-145
April 17, 2024
By VRG Therapeutics
VRG Therapeutics Advances VRG-145
White arrow icon up and right direction redirecting to Partner with US page
Latest
News
The latest industry news, interviews, technologies, and resources.
Team
May 14, 2024
By VRG Therapeutics
First stage gating meeting of the year
White arrow icon up and right direction redirecting to Partner with US page
Combi-X
VRG-145
April 17, 2024
By VRG Therapeutics
VRG Therapeutics Advances VRG-145
White arrow icon up and right direction redirecting to Partner with US page
View All News
Learn More
Million ways to improve life
Learn More
Million ways to improve life